DELIVRA HEALTH BRANDS INC (DHB.CA) Stock Price, Forecast & Analysis
Canada • TSX Venture Exchange • TSX-V:DHB • CA24703H2019
DHB.CA Key Statistics, Chart & Performance
The current stock price of DHB.CA is 0.195 CAD. In the past month the price decreased by -17.02%. In the past year, price decreased by -2.5%.
DHB.CA Technical Analysis
DHB.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DHB.CA. The financial health of DHB.CA is average, but there are quite some concerns on its profitability.
DHB.CA Financial Highlights
Over the last trailing twelve months DHB.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS decreased by -560.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.86% | ||
| ROE | -18.62% | ||
| Debt/Equity | 0.43 |
DHB.CA Forecast & Estimates
9 analysts have analysed DHB.CA and the average price target is 0.73 CAD. This implies a price increase of 276.62% is expected in the next year compared to the current price of 0.195.
For the next year, analysts expect an EPS growth of 80% and a revenue growth 13.99% for DHB.CA
DHB.CA Ownership
DHB.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.39 | 3.019B | ||
| GSD | DEVONIAN HEALTH GROUP INC | N/A | 1.659B | ||
| CRON | CRONOS GROUP INC | 36.74 | 1.367B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.211B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 7.14 | 902.702M | ||
| GUD | KNIGHT THERAPEUTICS INC | 124.02 | 590.775M | ||
| WEED | CANOPY GROWTH CORP | N/A | 552.69M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 393.546M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 27.22 | 370.148M | ||
| TSND | TERRASCEND CORP | N/A | 331.425M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About DHB.CA
Company Profile
Delivra Health Brands, Inc. is a cannabis company, which engages in the development and provision of health and wellness packaged goods to consumers and patients in regulated markets. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2010-02-02. The firm provides products that help with pain, sleep, anxiety, and performance through its brands LivRelief and Dream Water. The company operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and Delivra Corp. Dream Water provides non-habit-forming sleep solutions in formats to suit various consumer needs. The company features its proprietary SleepStat blend, a combination of melatonin, gamma-aminobutyric acid, and 5-hydroxytryptophan. Its product range includes 74ml (2.5oz) liquid sleep shots, gummies, and powder. Delivra Corp. manufactures and sells a growing line of topical creams with the proprietary transdermal delivery system platform under the LivRelief brand for conditions, such as joint and muscle pain, nerve pain, varicose veins, and wound healing creams. LivRelief Infused launched cannabidol and tetrahydrocannabinol-infused topical formulations through licensing agreements.
Company Info
DELIVRA HEALTH BRANDS INC
Suite 404, 999 Canada Place
Vancouver BRITISH COLUMBIA CA
Employees: 27
Phone: 16044499280
DELIVRA HEALTH BRANDS INC / DHB.CA FAQ
Can you describe the business of DELIVRA HEALTH BRANDS INC?
Delivra Health Brands, Inc. is a cannabis company, which engages in the development and provision of health and wellness packaged goods to consumers and patients in regulated markets. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2010-02-02. The firm provides products that help with pain, sleep, anxiety, and performance through its brands LivRelief and Dream Water. The company operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and Delivra Corp. Dream Water provides non-habit-forming sleep solutions in formats to suit various consumer needs. The company features its proprietary SleepStat blend, a combination of melatonin, gamma-aminobutyric acid, and 5-hydroxytryptophan. Its product range includes 74ml (2.5oz) liquid sleep shots, gummies, and powder. Delivra Corp. manufactures and sells a growing line of topical creams with the proprietary transdermal delivery system platform under the LivRelief brand for conditions, such as joint and muscle pain, nerve pain, varicose veins, and wound healing creams. LivRelief Infused launched cannabidol and tetrahydrocannabinol-infused topical formulations through licensing agreements.
What is the current price of DHB stock?
The current stock price of DHB.CA is 0.195 CAD. The price increased by 8.33% in the last trading session.
Does DHB stock pay dividends?
DHB.CA does not pay a dividend.
How is the ChartMill rating for DELIVRA HEALTH BRANDS INC?
DHB.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Is DELIVRA HEALTH BRANDS INC (DHB.CA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on DHB.CA.